Our top pick for
Squarespace Inc., based in New York City, wrapped its direct listing today, selling shares at $49.19 each.
Website hosting company Squarespace completed its direct listing, selling shares at $49.19 each. The company recently conducted a private funding round in which it sold about 4.45 million shares at $68.42 each.
Before you can invest in Squarespace, you'll need to open a brokerage account.
NYC-headquartered Squarespace was publicly launched in 2004. The platform saw 28% revenue growth from 2019 to 2020 with over 3.7 million unique subscriptions to its name as of December 31, 2020.
With the release of its S-1 filing, we were able to get a closer look at its financial performance over the past two years:
|Squarespace revenue||$484.7 million||$621.1 million|
|Squarespace net income||$58.1 million||$30.5 million|
Squarespace’s balance sheet indicates that the company is increasing its revenue and remains profitable — although its net income was substantially lower in 2020 than it was in 2019. Before you invest, be sure to carefully investigate the company’s performance to determine whether Squarespace stock will be a practical fit for your portfolio.
It's impossible to predict how any stock will perform — and IPOs can be particularly volatile. But evaluating the performance of companies like Squarespace can be useful in determining how the market is performing and whether now is a good time to invest in this industry.
Select a company to learn more about what they do and how their stock performs, including market capitalization, the price-to-earnings (P/E) ratio, price/earnings-to-growth (PEG) ratio and dividend yield. While this list includes a selection of the most well-known and popular stocks, it doesn't include every stock available.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.